Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

Author： Karagiannis Asterios Tziomalos Konstantinos Papageorgiou Athanasios Kakafika Anna I Pagourelias Efstathios D Anagnostis Panagiotis Athyros Vasilios G Mikhailidis Dimitri P

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.4, 2008-03, pp. : 509-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing

By Hood Sue Cannon John Foo Roger Brown Morris

Clinical Medicine, Vol. 5, Iss. 1, 2005-01 ,pp. : 55-60

Royal College Of Physicians

Access to resources Recommend Favorite

Working heart function in diabetes is not improved by spironolactone treatment

By Verma Subodh Yuen Violet G Badiwala Mitesh Anderson Todd J McNeill John H

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 5, 2003-05 ,pp. : 493-496

NRC Research Press

Access to resources Recommend Favorite

Eplerenone in hypertension

By Burgess Ellen

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2573-2581

Informa Healthcare

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Treatment strategies for juvenile idiopathic arthritis

By Klein Ariane Horneff Gerd

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3049-3060

Informa Healthcare

Access to resources Recommend Favorite